NOVEL COMPOUNDS OF REVERES TURN MIMETICS, THE PROCESS OF PREPARATION AND THE USE THEREOF
摘要
PURPOSE: A pharmaceutical composition containing reverse-turn mimetic with pyrazino-triazinone as a basic structure is provided to effectively suppress proliferation of acute myeloid leukemia cells. CONSTITUTION: A novel compound of reverse-turn mimetics is denoted by chemical formula I. A pharmaceutical composition contains the compound of chemical formula I and pharmaceutically acceptable excipient. A method for treating acute myelocytic leukemia(AML) comprises a step of administering effective amount of the pharmaceutical composition to a patient with AML. A method for preparing the compound of chemical formula I comprises: a step of introducing an acyl group to indole-7-carbaldehyde by Friedel-Crafts acylation to prepare 3-acyl-indole-7-carbaldehyde; a step of introducing alkyl groups and amino acetal groups to 3-acyl-indole-7-carbaldehyde to prepare a 1-alkyl-3-acyl-indole derivative; a step of performing amidation to prepare reaction intermediates; a step of cyclizing to prepare a cyclic intermediate; and a step of phosphating the cyclic intermediate.
申请公布号
KR20120028877(A)
申请公布日期
2012.03.23
申请号
KR20117026683
申请日期
2010.04.14
申请人
JW PHARMACEUTICAL CORPORATION
发明人
JUNG, KYUNG YUN;CHUNG, JAE UK;JEONG, MIN WOOK;JUNG, HEE KYUNG;LA, HYUN JU;MA, SANG HO;LEE, YONG SIL